Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Gleevec (STI571)
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Imatinib (Primary) ; Cytarabine; Interferon alpha
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 06 Dec 2016 Results from this and other five studies presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
- 24 Aug 2013 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center record.
- 24 Aug 2013 New source identified and integrated (M.D. Anderson Cancer Center; ID01-015).